- Home
- INBK vs KMDA Comparison
INBK vs KMDA Comparison
Compare INBK & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INBK
- KMDA
- Stock Information
- Founded
- INBK 1999
- KMDA 1990
- Country
- INBK United States
- KMDA Israel
- Employees
- INBK N/A
- KMDA N/A
- Industry
- INBK Major Banks
- KMDA Biotechnology: Pharmaceutical Preparations
- Sector
- INBK Finance
- KMDA Health Care
- Exchange
- INBK Nasdaq
- KMDA Nasdaq
- Market Cap
- INBK 363.3M
- KMDA 349.6M
- IPO Year
- INBK N/A
- KMDA N/A
- Fundamental
- Price
- INBK $37.58
- KMDA $5.89
- Analyst Decision
- INBK Buy
- KMDA Strong Buy
- Analyst Count
- INBK 4
- KMDA 2
- Target Price
- INBK $41.13
- KMDA $14.50
- AVG Volume (30 Days)
- INBK 26.9K
- KMDA 31.9K
- Earning Date
- INBK 01-22-2025
- KMDA 11-13-2024
- Dividend Yield
- INBK 0.64%
- KMDA N/A
- EPS Growth
- INBK 114.10
- KMDA 124.29
- EPS
- INBK 2.53
- KMDA 0.27
- Revenue
- INBK $108,980,000.00
- KMDA $158,380,000.00
- Revenue This Year
- INBK N/A
- KMDA $15.38
- Revenue Next Year
- INBK $16.32
- KMDA $6.18
- P/E Ratio
- INBK $14.88
- KMDA $21.95
- Revenue Growth
- INBK 26.53
- KMDA 4.52
- 52 Week Low
- INBK $23.04
- KMDA $4.74
- 52 Week High
- INBK $43.26
- KMDA $6.53
- Technical
- Relative Strength Index (RSI)
- INBK 39.78
- KMDA 50.76
- Support Level
- INBK $40.14
- KMDA $5.75
- Resistance Level
- INBK $41.10
- KMDA $5.90
- Average True Range (ATR)
- INBK 1.59
- KMDA 0.18
- MACD
- INBK -0.68
- KMDA -0.03
- Stochastic Oscillator
- INBK 19.34
- KMDA 35.00
About INBK First Internet Bancorp
First Internet Bancorp is a bank holding company. Through its subsidiaries, it provides commercial real estate (CRE) lending, including nationwide single tenant lease financing and commercial and industrial (C&I) lending, including business banking/treasury management services. The company offers its products and services through the internet and does not have any branches. With operations organized into a single segment called the Commercial Banking segment, it also provides retail banking services.
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, Proprietary Products segment and Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.